{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:31:50Z","timestamp":1773448310077,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"MSD"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>The aim of this study was to understand the perception of family physicians, pulmonologists, and allergists with respect to diagnostic tests performed on patients with chronic cough and treatments prescribed to patients with refractory or unexplained chronic cough. We also assessed how these health professionals perceived the effectiveness of these treatments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An anonymous survey was distributed by the scientific societies SEPAR, SEAIC, SEMERGEN, semFYC, and SEMG. Respondents were asked how often they perform diagnostic tests and prescribe treatments (responses from 1\u2009=\u2009never to 10\u2009=\u2009always) and how they perceived the effectiveness of the drugs used (from 1\u2009=\u2009not at all to 10\u2009=\u2009very effective). The correlation between perceived effectiveness and frequency of prescription was analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The respondents comprised 620 family physicians, 92 pulmonologists, and 62 allergists. The most frequently performed diagnostic tests were chest x-ray and, among pulmonologists and allergists, simple spirometry and bronchodilator tests. The most frequently prescribed drugs were bronchodilators (percentages scoring 8\u201310 for each specialty: 43.2%, 42.4%, and 56.5%;<jats:italic>p<\/jats:italic>\u2009=\u20090.127), inhaled corticosteroids (36.9%, 55.4%, and 54.8%;<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and antitussives (family physicians, 33.4%). Regarding perceived effectiveness, only bronchodilators, inhaled or oral corticosteroids, and opioids obtained a median effectiveness score\u2009&gt;\u20095 (between 6 and 7). Correlation coefficients (\u03c1<jats:sup>2<\/jats:sup>) suggested that approximately 45% of prescription was related to perceived effectiveness.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although chronic cough is a common problem, diagnosis and treatment differ among specialists. The perceived effectiveness of drugs is generally low.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s00408-021-00475-1","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T12:02:57Z","timestamp":1631880177000},"page":"507-515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A Survey of Physicians' Perception of the Use and Effectiveness of Diagnostic and Therapeutic Procedures in Chronic Cough Patients"],"prefix":"10.1007","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8501-0117","authenticated-orcid":false,"given":"Luis","family":"Puente-Maestu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Molina-Par\u00eds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan A.","family":"Trigueros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Tom\u00e1s","family":"G\u00f3mez-S\u00e1enz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Cea-Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabela","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"S\u00e1nchez-Jare\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Dom\u00ednguez-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"475_CR1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00408-015-9701-2","volume":"193","author":"SA Chamberlain","year":"2015","unstructured":"Chamberlain SA, Garrod R, Douiri A et al (2015) The impact of chronic cough: a cross-sectional European survey. Lung 193:401\u2013408. https:\/\/doi.org\/10.1007\/s00408-015-9701-2","journal-title":"Lung"},{"key":"475_CR2","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1183\/09031936.00218714","volume":"45","author":"WJ Song","year":"2015","unstructured":"Song WJ, Chang YS, Faruqi S et al (2015) The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur Respir J 45:1479\u20131481. https:\/\/doi.org\/10.1183\/09031936.00218714","journal-title":"Eur Respir J"},{"key":"475_CR3","doi-asserted-by":"publisher","first-page":"1901136","DOI":"10.1183\/13993003.01136-2019","volume":"55","author":"AH Morice","year":"2020","unstructured":"Morice AH, Millqvist E, Bieksiene K et al (2020) ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 55:1901136. https:\/\/doi.org\/10.1183\/13993003.01136-2019","journal-title":"Eur Respir J"},{"key":"475_CR4","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1183\/09031936.00218613","volume":"44","author":"AH Morice","year":"2014","unstructured":"Morice AH, Millqvist E, Belvisi MG et al (2014) Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J 44:1132\u20131148. https:\/\/doi.org\/10.1183\/09031936.00218613","journal-title":"Eur Respir J"},{"key":"475_CR5","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S2213-2600(18)30150-4","volume":"6","author":"SB Mazzone","year":"2018","unstructured":"Mazzone SB, Chung KF, McGarvey L (2018) The heterogeneity of chronic cough: a case for endotypes of cough hypersensitivity. Lancet Respir Med 6:636\u2013646. https:\/\/doi.org\/10.1016\/S2213-2600(18)30150-4","journal-title":"Lancet Respir Med"},{"key":"475_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S2213-2600(13)70043-2","volume":"1","author":"KF Chung","year":"2013","unstructured":"Chung KF, McGarvey L, Mazzone SB (2013) Chronic cough as a neuropathic disorder. Lancet Respir Med 1:414\u2013422","journal-title":"Lancet Respir Med"},{"key":"475_CR7","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/S2213-2600(16)30373-3","volume":"4","author":"KF Chung","year":"2016","unstructured":"Chung KF, McGarvey L, Mazzone S (2016) Chronic cough and cough hypersensitivity syndrome. Lancet Respir Med 4:934\u2013935. https:\/\/doi.org\/10.1016\/S2213-2600(16)30373-3","journal-title":"Lancet Respir Med"},{"key":"475_CR8","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1136\/thx.53.9.738","volume":"53","author":"LP McGarvey","year":"1998","unstructured":"McGarvey LP, Heaney LG, Lawson JT et al (1998) Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax 53:738\u2013743. https:\/\/doi.org\/10.1136\/thx.53.9.738","journal-title":"Thorax"},{"key":"475_CR9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1164\/ajrccm.160.2.9810100","volume":"160","author":"CE Brightling","year":"1999","unstructured":"Brightling CE, Ward R, Goh KL et al (1999) Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 160:406\u2013410. https:\/\/doi.org\/10.1164\/ajrccm.160.2.9810100","journal-title":"Am J Respir Crit Care Med"},{"key":"475_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.resmer.2019.04.005","volume":"76","author":"T Lamon","year":"2019","unstructured":"Lamon T, Didier A, Brouquieres D et al (2019) Exhaled nitric oxide in chronic cough: A good tool in a multi-step approach. Respir Med Res 76:4\u20139. https:\/\/doi.org\/10.1016\/j.resmer.2019.04.005","journal-title":"Respir Med Res"},{"key":"475_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.anai.2017.12.004","volume":"120","author":"MH Sadeghi","year":"2018","unstructured":"Sadeghi MH, Wright CE, Hart S et al (2018) Phenotyping patients with chronic cough: evaluating the ability to predict the response to anti-inflammatory therapy. Ann Allergy Asthma Immunol 120:285\u2013291. https:\/\/doi.org\/10.1016\/j.anai.2017.12.004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"475_CR12","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jaci.2004.03.019","volume":"113","author":"R Chaudhuri","year":"2004","unstructured":"Chaudhuri R, McMahon AD, Thomson LJ et al (2004) Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough. J Allergy Clin Immunol 113:1063\u20131070. https:\/\/doi.org\/10.1016\/j.jaci.2004.03.019","journal-title":"J Allergy Clin Immunol"},{"key":"475_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1081-1206(10)60623-0","volume":"99","author":"M Ribeiro","year":"2007","unstructured":"Ribeiro M, Pereira CA, Nery LE et al (2007) High-dose inhaled beclomethasone treatment in patients with chronic cough: a randomized placebo-controlled study. Ann Allergy Asthma Immunol 99:61\u201368. https:\/\/doi.org\/10.1016\/S1081-1206(10)60623-0","journal-title":"Ann Allergy Asthma Immunol"},{"key":"475_CR14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1164\/ajrccm.149.2.8306050","volume":"149","author":"LP Boulet","year":"1994","unstructured":"Boulet LP, Milot J, Boutet M et al (1994) Airway inflammation in nonasthmatic subjects with chronic cough. Am J Respir Crit Care Med 149:482\u2013489. https:\/\/doi.org\/10.1164\/ajrccm.149.2.8306050","journal-title":"Am J Respir Crit Care Med"},{"key":"475_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1155\/1999\/434901","volume":"6","author":"MM Pizzichini","year":"1999","unstructured":"Pizzichini MM, Pizzichini E, Parameswaran K et al (1999) Nonasthmatic chronic cough: no effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. Can Respir J 6:323\u2013330. https:\/\/doi.org\/10.1155\/1999\/434901","journal-title":"Can Respir J"},{"key":"475_CR16","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1183\/09031936.93.04091101","volume":"4","author":"GJ Wesseling","year":"1991","unstructured":"Wesseling GJ, Quaedvlieg M, Wouters EF (1991) Inhaled budesonide in chronic bronchitis. effects on respiratory impedance. Eur Respir J 4:1101\u20131105","journal-title":"Eur Respir J"},{"key":"475_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0140-6736(03)12459-2","volume":"361","author":"P Calverley","year":"2003","unstructured":"Calverley P, Pauwels R, Vestbo J et al (2003) Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 361:449\u2013456. https:\/\/doi.org\/10.1016\/S0140-6736(03)12459-2","journal-title":"Lancet"},{"key":"475_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1378\/chest.15-1496","volume":"149","author":"P Gibson","year":"2016","unstructured":"Gibson P, Wang G, McGarvey L et al (2016) Treatment of unexplained chronic cough: chest guideline and expert panel report. Chest 149:27\u201344. https:\/\/doi.org\/10.1378\/chest.15-1496","journal-title":"Chest"},{"key":"475_CR19","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1164\/rccm.200607-892OC","volume":"175","author":"AH Morice","year":"2007","unstructured":"Morice AH, Menon MS, Mulrennan SA et al (2007) Opiate therapy in chronic cough. Am J Respir Crit Care Med 175:312\u2013315","journal-title":"Am J Respir Crit Care Med"},{"key":"475_CR20","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1097\/01.mlg.0000244377.60334.e3","volume":"116","author":"A Jeyakumar","year":"2006","unstructured":"Jeyakumar A, Brickman TM, Haben M (2006) Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy. Laryngoscope 116:2108\u20132112. https:\/\/doi.org\/10.1097\/01.mlg.0000244377.60334.e3","journal-title":"Laryngoscope"},{"key":"475_CR21","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/S0140-6736(12)60776-4","volume":"380","author":"NM Ryan","year":"2012","unstructured":"Ryan NM, Birring SS, Gibson PG (2012) Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet 380:1583\u20131589. https:\/\/doi.org\/10.1016\/S0140-6736(12)60776-4","journal-title":"Lancet"},{"key":"475_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/0194599817703949","volume":"157","author":"GR Dion","year":"2017","unstructured":"Dion GR, Teng SE, Achlatis E, Fang Y et al (2017) Treatment of neurogenic cough with tramadol: a pilot study. Otolaryngol Head Neck Surg 157:77\u201379. https:\/\/doi.org\/10.1177\/0194599817703949","journal-title":"Otolaryngol Head Neck Surg"},{"key":"475_CR23","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/0194599812471817","volume":"148","author":"SM Cohen","year":"2013","unstructured":"Cohen SM, Misono S (2013) Use of specific neuromodulators in the treatment of chronic, idiopathic cough: a systematic review. Otolaryngol Head Neck Surg 148:374\u2013382","journal-title":"Otolaryngol Head Neck Surg"},{"key":"475_CR24","doi-asserted-by":"publisher","unstructured":"Wei W, Liu R, ZhangTong Y et al (2016) The efficacy of specific neuromodulators on human refractory chronic cough: a systematic review and meta-analysis. J Thorac Dis 8: 2942\u20132951 Doi: https:\/\/doi.org\/10.21037\/jtd.2016.10.51","DOI":"10.21037\/jtd.2016.10.51"},{"key":"475_CR25","doi-asserted-by":"publisher","first-page":"712","DOI":"10.5414\/CP202804","volume":"55","author":"JA Smith","year":"2017","unstructured":"Smith JA, McGarvey LPA, Badri H et al (2017) Effects of a novel sodium channel blocker, GSK2339345, in patients with refractory chronic cough. Int J Clin Pharmacol Ther 55:712\u2013719. https:\/\/doi.org\/10.5414\/CP202804","journal-title":"Int J Clin Pharmacol Ther"},{"key":"475_CR26","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1164\/rccm.201704-0769OC","volume":"196","author":"MG Belvisi","year":"2017","unstructured":"Belvisi MG, Birrell MA, Wortley MA et al (2017) XEN-D0501, a novel transient receptor potential vanilloid 1 antagonist, does not reduce cough in patients with refractory cough. Am J Respir Crit Care Med 196:1255\u20131263. https:\/\/doi.org\/10.1164\/rccm.201704-0769OC","journal-title":"Am J Respir Crit Care Med"},{"key":"475_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jaci.2014.01.038","volume":"134","author":"S Khalid","year":"2014","unstructured":"Khalid S, Murdoch R, Newlands A et al (2014) Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial. J Allergy Clin Immunol 134:56\u201362. https:\/\/doi.org\/10.1016\/j.jaci.2014.01.038","journal-title":"J Allergy Clin Immunol"},{"key":"475_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.pupt.2019.03.006","volume":"56","author":"D Muccino","year":"2019","unstructured":"Muccino D, Green S (2019) Update on the clinical development of gefapixant, a P2X3 receptor antagonist for the treatment of refractory chronic cough. Pulm Pharmacol Ther 56:75\u201378. https:\/\/doi.org\/10.1016\/j.pupt.2019.03.006","journal-title":"Pulm Pharmacol Ther"},{"key":"475_CR29","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S2213-2600(19)30471-0","volume":"8","author":"JA Smith","year":"2020","unstructured":"Smith JA, Kitt MM, Morice AH et al (2020) Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial. Lancet Respir Med 8:775\u2013785. https:\/\/doi.org\/10.1016\/S2213-2600(19)30471-0","journal-title":"Lancet Respir Med"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-021-00475-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-021-00475-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-021-00475-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T15:27:33Z","timestamp":1673278053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-021-00475-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1007\/s00408-021-00475-1","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"assertion":[{"value":"7 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Luis Puente-Maestu has received payment for consultancy services and presentations from MSD, AstraZeneca, Boston Scientific, Esteve, GSK, Chiesi, and Novartis. He has also been an adviser to AstraZeneca and has received institutional financial support from GSK, Esteve, Grifols, Zambon, Menarini, and Bial, as well as traveling and accommodation expenses for attendance at medical education meetings from Boston Scientific, Boehringer, Chiesi, and Novartis. Jes\u00fas Molina-Par\u00eds has received payment for acting as an adviser to GSK, acting as a consultant to AstraZeneca and GSK, and for preparing expert reports for GSK, AstraZeneca, Pfizer, and Novartis. Juan A. Trigueros has received research grants from GSK, AstraZeneca, Menarini, Teva, and Boehringer. J. Tom\u00e1s G\u00f3mez-S\u00e1enz has received payment for consultancy services and presentations from GSK, AstraZeneca, Reig Jofre, and Teva. Luis Cea-Calvo is a full-time employee of MSD, Spain. Sabela Fern\u00e1ndez is a full-time employee of MSD, Spain. Marta S\u00e1nchez-Jare\u00f1o is a full-time employee of MSD, Spain. Javier Dom\u00ednguez-Ortega has received payment for consultancy services and presentations from Leti Pharma, Mundipharma, AstraZeneca, Chiesi, Novartis, GSK, MSD, Sanofi, and Teva.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All the physicians consented to participate in the survey.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have reviewed and approved the final version of this manuscript and agree to the publication of the findings of the present study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}